A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control
This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol
Inclusion Criteria:
Patients with a diagnosis of asthma, and:
Exclusion Criteria:
Other protocol-defined inclusion/exclusion criteria may apply
Engelwood, Colorado 80112, United States